業績一覧
2025年 業績
Hisamatsu T, Naganuma M, Pinton P, Takeno M. Behçet's disease:incidence, prevalence and real-word data on the use of biologic agents in Japan. J Gastroenterol. 2025 Mar;60(3):294-305.
Mizuki Y, Horita N, Takeno M, Meguro A, Kirino Y, Kawagoe T, Sakono T, Ishihara M, Ohno S, Mizuki N. Epidemiological and clinical insights into Behçet's disease in Japan: a 2019 nationwide analysis. Mod Rheumatol. 2025 Oct 22:roaf103. doi: 10.1093/mr/roaf103. Online ahead of print.
Kusuhara S, Sonoda KH, Kaburaki T, Fujita T, Katayama S, Makishima M, Nakamura T, Nio M, Omoto T, Matsuo-Tezuka Y, Yoshizaki T, Sasaki K, Ri K, Sato K, Goto H. Real-world treatment patterns for patients with non-infectious uveitis in Japan: a descriptive study using a large-scale claims database (J-CAT study). J Ophthalmic Inflamm Infect. 2025 Jul 22;15(1):56.
Lee C, Takeuchi M, Kawagoe T, Nakamura J, Shibuya E, Ishihara M, Yamada N, Mizuki Y, Meguro A, Kirino Y, Soejima Y, Hirahara L, Iizuka Y, Mizuki N. Effectiveness and safety of biosimilar infliximab CT-P13 in the treatment of refractory uveitis associated with Behçet's disease. Jpn J Ophthalmol. 2025 Sep;69(5):798-804.
Nagafuchi H, Ando T, Mizushima M, Ooka S, Kawahata K. Enthesitis in patients with Behçet's disease: a single-centre retrospective cohort study in Japan. Mod Rheumatol. 2025 Oct 28;35(6):1030-1034.
Tsutsui H, Hoshino H, Shiba K, Fukasawa T, Kikuchi H, Oguchi H, Ohkubo T, Kono H. Relation of social participation restrictions with worsening quality of life in Japanese patients with Behçet's disease The 36-item Short Form Survey. JMA J. 2025 Jan 15;8(1):151-164
Ichikawa K, Adachi S, Takase-Minegishi K, Nakayama Y, Nagasawa Y, Iizuka Y, Maeda A, Hirahara L, Soejima Y, Ohashi T, Kunimoto H, Horita N, Yoshimi R, Kirino Y, Nakajima H. Distinct features of trisomy 8-associated autoinflammatory disease from Behcet's disease: case series and systematic review. Clin Exp Rheumatol. 2025 Oct;43(10):1718-1725.
Shirai H, Saito-Sato N, Horiuchi E, Kikuchi H, Kadowaki S, Ohnishi H, Suzuki T. Case report: Adult case of A20 haploinsufficiency suspected as neuro-Behcet disease. Front Immunol. 2025 Jan 7;15:1508307.
Fukui T, Naganuma M, Kirino Y, Kunisaki R, Mikami Y, Ueno N, Umeno J, Bamba S, Ooi M, Hosomi S, Matsumoto T, Matsuoka K, Watanabe C, Nagahori M, Uchino M, Watanabe K, Hirai F, Matsuura M, Tanaka Y, Takeno M, Hisamatsu T. A Multicenter observational study for the establishment of novel severity criteria including endoscopic evaluation for intestinal Behçet's disease. Dig Endosc. 2025 Sep 27. doi: 10.1111/den.70041. Online ahead of print.
Hirohata S, Kikuchi H, Sawada T, Tono T, Kawachi I, Takeno M. Development of severity classification criteria for acute neuro-Behçet's disease. Intern Med. 2025 Jun 12. doi: 10.2169/internalmedicine.5496-25. Online ahead of print.
Kusuhara S, Sonoda K, Kaburaki T, Fujita T, Katayama S, Makishima M, Nakamura T, Nio M, Omoto T, Matsuo-Tezuka Y, Yoshizaki T, Sasaki K, Ri K, Sato K, Goto H. Real-world treatment patterns for patients with non-infectious uveitis in Japan: a descriptive study using a large-scale claims database (J-CAT study). J Ophthalmic Inflamm Infect. 2025 Jul 22;15(1):56. doi: 10.1186/s12348-025-00514-5.
Tsubota K, Usui Y, Shimizu H, Goto H. Identification of markers predicting clinical course in patients with Behçet's disease by combination of machine learning and unbiased clustering analysis. Graefes Arch Clin Exp Ophthalmol. 2025 Sep;263(9):2641-2650.
Sugawara R, Usui Y, Tsubota K, Goto H. Long-term Outcomes of Uveoretinitis in Behçet’s Disease in the Era of Biologic Treatments: A 10-Year Follow-up Study. Ocul Immunol Inflamm. 2025: 33, 913-919.
Kirino Y, Takeuchi M, Gül A. Immunogenetics of Behçet's disease: Is there a link to recent phenotypic changes? Saudi J Ophthalmol. 2025;39(4):323-328.
Naganuma M, Takeno M, Çelik AF, Moots R, Pinton P, Hisamatsu T. Assessment of IL-6 Pathway Inhibition in Gastrointestinal Behçet's Disease from Immunological and Clinical Perspectives. Biomedicines. 2025 Jan 20;13(1):247. doi: 10.3390/biomedicines13010247.
Shiraki M, Kadowaki S, Miwa Y, Nishimura K, Maruyama Y, Kishida D, Imagawa K, Kobayashi C, Takada H, Mitsunaga K, Inoue Y, Ebato T, Miyamoto T, Hiejima E, Sato S, Migita K, Matsubayashi T, Kobayashi D, Hasegawa E, Kaneko U, Ishikawa T, Onodera M, Matsushita K, Koike Y, Umebayashi H, Kakuta F, Abukawa D, Funakoshi Y, Ishimura M, Otani Y, Nishizawa T, Ishige T, Hatori R, Tanaka S, Kusunoki S, Nakamura K, Shirai H, Hatai Y, Miyaoka F, Kaneko S, Shimbo A, Shimizu M, Kanegane H, Hashimoto M, Negoro N, Yoshida T, Wada Y, Usami M, Wada T, Izawa K, Yasumi T, Nishikomori R, Ohnishi H. Clinical characteristics and treatment strategies for A20 haploinsufficiency in Japan: a national epidemiological survey. Front Immunol. 2025 Jun 12:16:1548042. doi: 10.3389/fimmu.2025.1548042.
